A. ROC curve analysis for prediction of mortality according to APRI score > 1.5, FIB-4 score > 2.67 and NAFLD fibrosis score > 0.676. B. ROC curve analysis for prediction of composite outcomes of ascites, esophageal varices, hepatic encephalopathy, liver transplantation, TIPS and hospitalizations according to APRI score > 1.5, FIB-4 score > 2.67 and NAFLD fibrosis score (NFS) > 0.676.</p
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
Background and Objectives: Upper endoscopy is considered the gold standard for screening and diagnos...
BACKGROUND AND AIM: Progression to fibrosis in non-alcoholic fatty liver disease (NAFLD) is associat...
BACKGROUND:Liver fibrosis predicts liver-related morbidity and mortality in patients with non-alcoho...
Background & Aims: Non-invasive scoring systems (NSS) are used to identify patients with non-alc...
[Background and Aim] There is debate among the hepatology community regarding the simple non-invasiv...
<p>The ROC analyses indicate the threshold for M65 (a) and M30 (b) for the best compromise sensitivi...
A. ROC curves of the 3-month mortality prediction among the three scores (n = 811). The AUC were 0.7...
UNLABELLED: BACKGROUNDAIMS: The BARD score is a model to detect advanced liver fibrosis in nonalcoho...
Objective. In recent years, the noninvasive serological scoring system has become a research hotspot...
Nonalcoholic fatty liver disease (NAFLD) is an emerging cause of liver-related events (LREs). Here, ...
Background The presence of advanced liver fibrosis portends a poor prognosis in nonalcoholic fatty l...
The prognosis of nonalcoholic fatty liver disease (NAFLD) patients depends on liver-related events (...
Non-alcoholic fatty liver disease (NAFLD) can progress from simple steatosis to hepatocellular carci...
It remains unclear whether screening for advanced fibrosis in the community can identify the subgrou...
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
Background and Objectives: Upper endoscopy is considered the gold standard for screening and diagnos...
BACKGROUND AND AIM: Progression to fibrosis in non-alcoholic fatty liver disease (NAFLD) is associat...
BACKGROUND:Liver fibrosis predicts liver-related morbidity and mortality in patients with non-alcoho...
Background & Aims: Non-invasive scoring systems (NSS) are used to identify patients with non-alc...
[Background and Aim] There is debate among the hepatology community regarding the simple non-invasiv...
<p>The ROC analyses indicate the threshold for M65 (a) and M30 (b) for the best compromise sensitivi...
A. ROC curves of the 3-month mortality prediction among the three scores (n = 811). The AUC were 0.7...
UNLABELLED: BACKGROUNDAIMS: The BARD score is a model to detect advanced liver fibrosis in nonalcoho...
Objective. In recent years, the noninvasive serological scoring system has become a research hotspot...
Nonalcoholic fatty liver disease (NAFLD) is an emerging cause of liver-related events (LREs). Here, ...
Background The presence of advanced liver fibrosis portends a poor prognosis in nonalcoholic fatty l...
The prognosis of nonalcoholic fatty liver disease (NAFLD) patients depends on liver-related events (...
Non-alcoholic fatty liver disease (NAFLD) can progress from simple steatosis to hepatocellular carci...
It remains unclear whether screening for advanced fibrosis in the community can identify the subgrou...
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
Background and Objectives: Upper endoscopy is considered the gold standard for screening and diagnos...
BACKGROUND AND AIM: Progression to fibrosis in non-alcoholic fatty liver disease (NAFLD) is associat...